SCNX

Company Overview — What Does Scienture Holdings, Inc. Do?

SCIENTURE HOLDINGS, Inc is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the U.S. Scienture Holdings, Inc. (SCNX) is classified as a micro-cap stock in the Consumer Staples sector, specifically within the Wholesale industry. The company is led by CEO Surendra Ajjarapu. With a market capitalization of $12M, SCNX is one of the notable companies in the Consumer Staples sector.

Scienture Holdings, Inc. (SCNX) Stock Rating — Avoid (April 2026)

As of April 2026, Scienture Holdings, Inc. receives a Avoid rating with a composite score of 13.9/100 and 1 out of 5 stars from the Blank Capital Research quantitative model.SCNX ranks #4,426 out of 4,446 stocks in our coverage universe. Within the Consumer Staples sector, Scienture Holdings, Inc. ranks #180 of 180 stocks, placing it in the lower half of its Consumer Staples peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

SCNX Stock Price and 52-Week Range

Scienture Holdings, Inc. (SCNX) currently trades at $0.33. The stock lost $0.01 (2.3%) in the most recent trading session. The 52-week high for SCNX is $2.60, which means the stock is currently trading -87.2% from its annual peak. The 52-week low is $0.37, putting the stock -10.5% above its annual trough. Recent trading volume was 438K shares, suggesting relatively thin trading activity.

Is SCNX Overvalued or Undervalued? — Valuation Analysis

Scienture Holdings, Inc. (SCNX) carries a value factor score of 8/100 in the Blank Capital model, signaling premium valuation that prices in significant future growth. The price-to-book ratio stands at 0.19x, versus the sector average of 1.74x. The price-to-sales ratio is 20.02x, compared to 0.35x for the average Consumer Staples stock.

At current multiples, Scienture Holdings, Inc. trades at a premium to most Consumer Staples peers. This elevated valuation may be justified if the company can sustain above-average growth rates and profitability, but it also creates downside risk if earnings disappoint expectations.

Scienture Holdings, Inc. Profitability — ROE, Margins, and Quality Score

Scienture Holdings, Inc. (SCNX) earns a quality factor score of 11/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is -23.6%, compared to the Consumer Staples sector average of 7.7%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -19.7% versus the sector average of 3.1%.

On a margin basis, Scienture Holdings, Inc. reports gross margins of 51.7%, compared to 26.2% for the sector. The operating margin is -178929.4% (sector: 2.9%). Net profit margin stands at -153598.0%, versus 1.6% for the average Consumer Staples stock. Revenue growth is running at 3055.5% on a trailing basis, compared to 3.1% for the sector. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.

SCNX Debt, Balance Sheet, and Financial Health

Scienture Holdings, Inc. has a debt-to-equity ratio of 20.0%, compared to the Consumer Staples sector average of 72.0%. The low leverage indicates a conservative balance sheet with significant financial flexibility. The current ratio is 2.89x, indicating strong short-term liquidity. Total debt on the balance sheet is $2M. Cash and equivalents stand at $355,692.

SCNX has a beta of 1.72, meaning it is more volatile than the broader market — a $10,000 investment in SCNX would be expected to move 71.9% more than the S&P 500 on any given day. The stability factor score for Scienture Holdings, Inc. is 8/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.

Scienture Holdings, Inc. Revenue and Earnings History — Quarterly Trend

In TTM 2026, Scienture Holdings, Inc. reported revenue of $655,584 and earnings per share (EPS) of $-2.70. Net income for the quarter was $-17M. Gross margin was 51.7%. Operating income came in at $-17M.

In FY 2025, Scienture Holdings, Inc. reported revenue of $431,609 and earnings per share (EPS) of $-2.70. Net income for the quarter was $-42M. Gross margin was 76.8%. Revenue grew 215.9% year-over-year compared to FY 2024. Operating income came in at $-43M.

In Q3 2025, Scienture Holdings, Inc. reported revenue of $590,050 and earnings per share (EPS) of $-0.19. Net income for the quarter was $-4M. Gross margin was 97.4%. Revenue grew 809.7% year-over-year compared to Q3 2024. Operating income came in at $-4M.

In Q2 2025, Scienture Holdings, Inc. reported revenue of $0 and earnings per share (EPS) of $-0.48. Net income for the quarter was $-7M. Operating income came in at $-5M.

Over the past 8 quarters, Scienture Holdings, Inc. has demonstrated a growth trajectory, with revenue expanding from $18,699 to $655,584. Investors analyzing SCNX stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

SCNX Dividend Yield and Income Analysis

Scienture Holdings, Inc. (SCNX) does not currently pay a dividend. This is common among smaller companies in the Wholesale industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Consumer Staples dividend stocks may want to explore other Consumer Staples stocks or use the stock screener to filter by dividend yield.

SCNX Momentum and Technical Analysis Profile

Scienture Holdings, Inc. (SCNX) has a momentum factor score of 10/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 20/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 44/100 reflects moderate short selling activity.

SCNX vs Competitors — Consumer Staples Sector Ranking and Peer Comparison

Within the Consumer Staples sector, Scienture Holdings, Inc. (SCNX) ranks #180 out of 180 stocks based on the Blank Capital composite score. This places SCNX in the lower half of all Consumer Staples stocks in our coverage universe. Key competitors and sector peers include Ituran Location & Control Ltd. (ITRN) with a score of 60.3/100, DARLING INGREDIENTS INC. (DAR) with a score of 52.9/100, Bunge Global SA (BG) with a score of 53.0/100, SANFILIPPO JOHN B & SON INC (JBSS) with a score of 54.1/100, and Archer-Daniels-Midland Co (ADM) with a score of 52.2/100.

Comparing SCNX against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full SCNX vs S&P 500 (SPY) comparison to assess how Scienture Holdings, Inc. stacks up against the broader market across all factor dimensions.

SCNX Next Earnings Date

No upcoming earnings date has been announced for Scienture Holdings, Inc. (SCNX) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy SCNX? — Investment Thesis Summary

The quantitative profile for Scienture Holdings, Inc. suggests caution. The quality score of 11/100 flags below-average profitability. The value score of 8/100 indicates premium valuation. Momentum is weak at 10/100, a headwind for near-term performance. High volatility (stability score 8/100) increases portfolio risk.

In summary, Scienture Holdings, Inc. (SCNX) earns a Avoid rating with a composite score of 13.9/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on SCNX stock.

Related Resources for SCNX Investors

Explore more research and tools: SCNX vs S&P 500 comparison, top Consumer Staples stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare SCNX head-to-head with peers: SCNX vs ITRN, SCNX vs DAR, SCNX vs BG.